Phio Pharmaceuticals Corp. (PHIO)

SEC filing

Phio Pharmaceuticals Corp.

PHIO · CIK 1533040

4 · Sep 15, 2026 · Director, Chairman, Pres. & CEO Bitterman Robert J reported 68.55K Common Stock, $.0001 par value

Director, Chairman, Pres. & CEO Bitterman Robert J reported 68.55K Common Stock, $.0001 par value

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).